Defecetive Drugs: adrugrecall.com
NEWS
Sign up for our newsletter
to receive breaking news about drugs to watch
Contact A Lawyer
Near You
Contact us today for a complimentary consultation with a qualified attorney near you.
Subscribe To Our Syndicated NewsDoctors Warned and Trasylol Trial Halted
-October 26, 2007
The trial for Bayer AG's heart medication, Trasylol, has been put on hold after new risks were reported in relation to the drug.
Trasylol is typically used for heart surgery and new data shows that there is an increased risk of bleeding to death linked with taking it.
Medication Investigated
The heart medication, which was approved by the FDA in 1993, is generically known as aprotinin.
Trasylol is used to prevent blood loss in patients during heart bypass surgery.
For more than a year it has been under investigation after reports suggested it could be associated with an increased risk in death, stroke and kidney damage.
FDA Warns Doctors
This week, the FDA issued a warning to doctors to be aware of these new reports.
The drug has recently been linked to serious bleeding and deaths caused by hemorrhage.
The drug's labeling was reportedly revised last year in order to determine which patients using it have an increased risk of blood loss and transfusion.
The drug's manufacturers, Bayer, also recently admitted that it withheld a study of 67,000 hospital records suggesting Trasylol may boost the risk of death, serious kidney damage and congestive heart failure.
(Source: The New York Times)
Have you been harmed by the heart medication Trasylol? If so, please contact us to speak with an experienced drug recall attorney who will enable you to receive compensation for any harm that has been done.
